ISB News

Dr. Jeff Ranish Promoted to Professor

We are pleased to announce the promotion of Jeff Ranish to Professor. Jeff has been a pioneer in the fields of mass spectrometry and gene regulation. His impressive history of innovation in mass spectrometry technology has produced novel protein-crosslinking approaches to identify large scale protein-protein interactions in complex mixtures. He has applied the innovations to important biological problems, resulting in notable findings such as the characterization of multiple topological and functional regions within transcription factor TFIIH, identification of multiple regulatory factors in the system of liver X receptor-retinoic acid receptor (LXR-RXR) heterodimers, and a quantitative approach to identify amounts of transcription factors during erythropoiesis. Jeff’s numerous collaborations with leading biologists have maximized the impact of his technological advances and produced significant advances in the understanding of transcriptional regulation. We look forward to Jeff’s continued success with research efforts that combine technological innovation with rigorous experimentation, providing an indispensable bridge between molecular biology and the systems perspective at ISB.

Recent Articles

  • Spotlight on ISB Education graphic

    2023-24 School Year ISB Education Highlights

    Each month throughout the 2023-2024 academic year, we will highlight some of the top projects the ISB Education team is working on. In March, ISB Education highlights include a paper published in a Nature Portfolio journal, two events for science/STEM leaders, and more.

  • STEM Program Models for Students from Historically Marginalized Communities

    A new study unveils important insights and actionable protocols into providing equitable STEM experiences for high school students from historically marginalized communities. The research highlights the transformative power of informal STEM learning and the ease with which many organizations could provide these opportunities.

  • Common Immune Response Protective Across Many Diseases

    Infection, autoimmunity and cancer account for 40 percent of deaths worldwide. In a Cell Reports paper, ISB researchers detail how the human immune system works in common ways across diseases – findings that offer promising avenues for exploring multi-disease therapeutic strategies.